l

- Company
- History




- Joined a GenomeAsia 100K consortium

- Signed an agreement 'Partnership for genetic information based precision medicine research'
with KUMC

- Signed an agreement 'Partnership for cancer targeted precision medicine research' with NCC

- Market section affiliation has shifted to 'KODAQ prime company'
- Selected as a 'KOSDAQ rising star 2016' by the Korea Exchange

- Selected as a 'World Class 300 company' by 'the Ministry of trade, industry&energy' and 'the Small&Medium Business Administration'
- Signed an agreement 'Sequencing based precision medicine research for cancer and incurable diseases' with Kyungpook national university medical center

- Signed a contract with 'Shaanxi Chang'an Health Management Institute Co., Ltd.' for establishment of joint venture in China

- Published 'De novo assembly and phasing of a Korean human Genome' in Nature with GMI

- Established 'Genstory', a joint venture with 'LG Household&Health Care Ltd.'
- Awarded 'Three Million Dollar Export Tower' at '53th Annual Trade Day'
- Awarded ‘2016 Best Family Freiendly Management' by Ministry of Gender Equality and Family

- Launched a new CI and slogan

- Selected as an institute for a ‘Young female researcher supporting program’ by the Ministry of trade, industry&energy
- Selected as a ‘KOSDAQ rising star 2015’ by the Korea Exchange

- Selected as a managing institute for a project 'Development of Korean FoundationMedicine model for personalized cancer treatment' by Ministry of Trade, Industry and Energy

- Awarded for the‘Certification of Excellence Authority of Human Resource Development’by Human Resources Development Service of Korea (co-certified by Ministry of Employment and Labor, Ministry of Education, Ministry of Trade, Industry and Energy, the Small&Medium Business Administration)

- Awarded by Ministry of Trade, Industry and Energy on a 'Company globalization promotion program'

- Awarded a Commendation of Minster of Labor for 'Merit of Job Creation' by Ministry of Labor
- Awarded 'Two Million Dollar Export Tower' at '52th Annual Trade Day'
- Macrogen Corp. acquired MCL and Axeq Technologies, Inc.

- Contracted with Illumina as a priority client for HiSeq X Ten
- Selected as an institute for ‘Work and Education paralleling support program’ by Ministry of Employment and Labor

- Selected as an institute for ‘Learning organization support program’ by Ministry of Employment and Labor

- Acquired Agilent CSP(Certified Service Provider) Certification

- Selected as a 'Hidden Champion of Kosdaq 2014' by KRX(Korea Exchange)
- Designated as a 'Next Global Champ' by the Ministry of trade, industry and energy.

- Contracted with ToolGen, Inc. for a collaboration on transgenic&knockout mouse business.
- Selected as an institute for ‘supporting program for hiring foreign experts’ by the Small and Medium Business Administration

- Selected as an ‘Infrastructure of learning organization supporting program’ by the Ministry of Employment and Labor

- Published "An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator" and other 3 papers in Nature and Nature Communicationsin collaboration with Genomic Medicine Institute, Seoul National University, College of Medicine
- MG MED, a subsidiary of Macrogen listed on KONEX market
- Awarded for a ‘Great Work Place’ from Small and Medium Business Administration & Ministry of Employment and Labor

- Awarded for the the 'Outstanding Enterprise Of Job Creation in 2012' by the Seoul Metropolis

- Awarded for managing department of ATC(Advanced Technology Center) from Ministry of Trade, Industry & Energy

- MCL ,Certified CLIA(Clinical Laboratory Improvement Amendments) For Clinical Sequencing Service

- Expanded and upgraded a state of the art SPF mouse facility (Deungchon, Seoul, Korea)
- Signed a business partnership agreement with Ahn-gook Pharmacy and CapitalBio for systematic construction of local cooperation in China

- Received the presidential award for Venture activation ‘Korea Venture-Start up Festival 2013’

- Certified CE Mark of Macrogen BAC chip H1440 for chromosomal anomalies

- Signed a business partnership agreement with Ahn-gook Pharm for the maketing and sales of the G-Scanning service, genetic disorder screening service in China

- Signed a business partnership agreement with Dong-A Pharm for co-research of new drug

- Signed a co-development agreement with Oscotec for the personalized lung cancer drug

- Awarded for 'KB Hidden Star' by KB Financial Group Inc.

- Published "The transcriptional landscape and mutational profile of lung adenocarcinoma" in Genome Research in collaboration with Genomic Medicine Institute, Seoul National University, College of Medicine.
- Awarded for the 'Certification of Excellence Authority of Human Resource Development' by Human Resources Development Service of Korea (co-certified by Ministry of Employment and Labor, Ministry of Education, Science and Technology, Ministry of Knowledge Economy, the Small and Medium Business Administration)

- Established Macrogen Clinical Laboratory, Inc. in the U.S

- Certified ISO13485:2003 for the in-vitro diagnostic device.

- Launched the Global Premium Sequencing Brand, 'AxeqTM'

- Published "Extensive genomic and transcriptional diversity identified through massively parallel DNA and RNA sequencing of eighteen Korean individuals" in Nature Genetics in collaboration with Genomic Medicine Institute, Seoul National University, College of Medicine.

- Awarded 'One Million Dollar Export Tower' in the 48 Annual Trade Day
- Published "Fusion of KIF5B and RET transforming gene in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing" in Genome Research in collaboration with Genomic Medicine Institute, Seoul National University, College of Medicine.